Back to WA Weiss Asset Management LP

ALXNALXN

Showing 0 of 3 quarters

Position history for WAWeiss Asset Management LP's holdings in ALEXION PHARMACEUTICALS INC

As of its Q2 2021 13F, Weiss Asset Management held 274,142 shares of ALXN (Alexion Pharmaceuticals), worth $50.4M. Weiss Asset Management's 13F filings listed ALXN from Q1 2021 to Q2 2021, 2 quarterly filings. ALXN was 1.3% of Weiss Asset Management's reported 13F portfolio.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

—

No position history available for this security.

Optional analytics helps us improve. How it’s used